Caplin Point Laboratories Ltd.
CAPLIPOINT Share PricePharmaceuticals & Drugs
₹1,976.1
87.9 (4.7%)
As on December 4, 2025
Exchange Scrips: BSE524742NSECAPLIPOINTISININE475E01026
Market Cap ₹ 14,935 Cr
P/E Ratio 28
Dividend Yield 0.15 %
Performance
Market performance
Open1,874.9
High1,985
Volumes1,22,324
Prev1,976.1
Low1,872.4
As on2025-12-04
Historical performance
1 Year High2,641
3 Year High2,641
5 Year High2,641
1 Year Low1,599
3 Year Low575
5 Year Low401
Fundamentals
Company Valuation
Market Cap (₹Cr)
14,935
Face Value (₹)
2
P/E Ratio
28
Dividend Yield
0.15 %
Investment Returns
1 Year
-16.4%
3 Years
159.7%
5 Years
301.3%
10 Years
603.4%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 1,920.72 | Bullish |
| 10-DMA | 1,917.38 | Bullish |
| 20-DMA | 1,925.76 | Bullish |
| 50-DMA | 1,991.73 | Bearish |
| 100-DMA | 2,061.9 | Bearish |
| 200-DMA | 2,028.88 | Bearish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 7 | 7 | 7 | 7 | 7 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 7 | 7 | 7 | 7 | 7 |
| Public Investors | 93746 | 94162 | 96380 | 92695 | 96116 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 28.0.
- 3Y Stock Price CAGR of the stock is 37.2.
- The stock has a beta of 1.6.
- In the last financial year, the company had an EBITDA of ₹7434 Million.
- The company generated revenue of ₹19375 Million in the previous financial year.
Caplin Point Laboratories Ltd.
1976.187.9 (4.7%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 830119.7
No. of Shares: 420 (Approx)
Performance:-17%
P/L: ₹-169880.3
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
